We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

IP Practice: Sidley Austin

Law360 (August 18, 2008, 12:00 AM EDT) -- The number of Hatch-Waxman Act-related lawsuits will likely drop over the next five years, but generic companies may start to challenge biotechnology patents, said the co-head of Sidley Austin's intellectual property...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.